Skip to main content
Premium Trial:

Request an Annual Quote

IntegraGen Opens Subsidiary in US; Former Roche Exec Will Be CEO

NEW YORK (GenomeWeb News) — IntegraGen today said it has established a US subsidiary and has hired former Roche Diagnostics executive Robert Gottlieb to be its new CEO.
 
The wholly-owned subsidiary, IntegraGen Inc., will be based in New York.  Gottlieb will retain his role as vice president of global sales and marketing for the IntegraGen Group, which is located outside Paris.
 
Parent company Integragen uses gene-mapping products to develop molecular diagnostic products and operates a diagnostic and counseling center for diabetes in Bonn, Germany.
 
Gottlieb said the US division will begin plans to commercialize an undisclosed product in the US. The company said its diagnostic and gene-mapping efforts are currently targeted toward type-2 diabetes, obesity, autism, and bi-polar disorder.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.